NASDAQ: TXMDTherapeuticsmd Inc Stock Ownership - Who owns Therapeuticsmd?
Insider buying vs selling
Have Therapeuticsmd Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Tommy G. Thompson | Director | 2025-04-14 | 325 | $1.00 | $325.65Buy |
| Marlan D. Walker | Chief Executive Officer | 2025-04-14 | 490 | $1.00 | $489.51Buy |
| Marlan D. Walker | Chief Executive Officer | 2025-04-10 | 1,167 | $0.86 | $1.00kBuy |
| Marlan D. Walker | Chief Executive Officer | 2025-04-09 | 1,136 | $0.88 | $994.00Buy |
TXMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TXMD insiders and whales buy or sell their stock.
TXMD Shareholders
What type of owners hold Therapeuticsmd Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brian Bernick | 265.18% | 30,693,311 | $39.59M | Insider |
| Robert G. Finizio | 172.72% | 19,991,637 | $25.79M | Insider |
| John Ck Milligan Iv | 88.40% | 10,231,927 | $13.20M | Insider |
| Nicholas Segal | 42.06% | 4,868,382 | $6.28M | Insider |
| Kimberly Sarubbi | 35.49% | 4,108,107 | $5.30M | Insider |
| Robin Natalie Tjon | 35.49% | 4,108,107 | $5.30M | Insider |
| Sky B. Kelley | 29.58% | 3,423,422 | $4.42M | Insider |
| Rubric Capital Management LP | 25.46% | 2,946,908 | $3.80M | Insider |
| Cooper C. Collins | 23.26% | 2,692,095 | $3.47M | Insider |
| Tommy G. Thompson | 22.24% | 2,574,614 | $3.32M | Insider |
TXMD vs Pharmaceutical Stocks
Therapeuticsmd Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.